| Alexander Asher Grunsfeld, MD | |
|
301 Riverview Ave, Ste 202, Norfolk, VA 23510-1065 | |
| (757) 252-9015 | |
| (757) 510-9041 |
| Full Name | Alexander Asher Grunsfeld |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 22 Years |
| Location | 301 Riverview Ave, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093755639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 0101239157 (Virginia) | Primary |
| 2084V0102X | Psychiatry & Neurology - Vascular Neurology | 0101239157 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Northern Virginia Medical Center | Woodbridge, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Martha Jefferson Hospital | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
"A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a study released on Thursday, with far more of the world's population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease," the New York Times reports.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.
Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour.
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza's extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control tools.
› Verified 4 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
"A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a study released on Thursday, with far more of the world's population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease," the New York Times reports.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.
Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour.
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza's extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control tools.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Asher Grunsfeld, MD 301 Riverview Ave, Ste 202, Norfolk, VA 23510-1065 Ph: (757) 252-9015 | Alexander Asher Grunsfeld, MD 301 Riverview Ave, Ste 202, Norfolk, VA 23510-1065 Ph: (757) 252-9015 |
News Archive
"A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a study released on Thursday, with far more of the world's population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease," the New York Times reports.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.
Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour.
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza's extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control tools.
› Verified 4 days ago
Peter M Dozier, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-8866 Fax: 757-668-8870 | |
Dr. Crystal Miller Proud, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Southampton Ave, Norfolk, VA 23510 Phone: 757-668-9920 Fax: 757-668-9930 | |
James Richard Wyant, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 8610, Norfolk, VA 23507 Phone: 757-252-9015 Fax: 757-510-9041 | |
Dr. Paul A Sayegh, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Mary Margaret Gleason, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 401 Gresham Dr, Norfolk, VA 23507 Phone: 577-668-4673 | |
Dr. Jerry H Morewitz, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Dr. C. Arthur Nalls Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6353 Center Drive, Ste 204, Norfolk, VA 23502 Phone: 757-461-3313 Fax: 757-461-8363 |